Dark Forest Capital Management LP Increases Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Dark Forest Capital Management LP increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 154.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,343 shares of the company's stock after purchasing an additional 4,457 shares during the quarter. Dark Forest Capital Management LP's holdings in GE HealthCare Technologies were worth $574,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Cherry Creek Investment Advisors Inc. raised its stake in shares of GE HealthCare Technologies by 0.3% during the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock worth $2,920,000 after buying an additional 114 shares during the period. Independence Bank of Kentucky raised its stake in GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock worth $158,000 after purchasing an additional 114 shares during the period. Haverford Trust Co grew its stake in shares of GE HealthCare Technologies by 2.4% in the 4th quarter. Haverford Trust Co now owns 4,896 shares of the company's stock valued at $383,000 after buying an additional 115 shares during the period. Tandem Capital Management Corp ADV increased its stake in GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock worth $2,205,000 after acquiring an additional 118 shares during the last quarter. Finally, Arcus Capital Partners LLC grew its holdings in shares of GE HealthCare Technologies by 3.0% during the 4th quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock worth $322,000 after purchasing an additional 119 shares during the period. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC traded up $1.89 during trading hours on Wednesday, reaching $69.98. The stock had a trading volume of 8,143,829 shares, compared to its average volume of 4,034,014. The firm has a market cap of $32.04 billion, a price-to-earnings ratio of 16.16, a PEG ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm has a 50-day moving average of $75.62 and a 200-day moving average of $81.81. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $4.78 billion for the quarter, compared to analyst estimates of $4.66 billion. During the same period last year, the firm posted $0.90 earnings per share. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.20%. GE HealthCare Technologies's dividend payout ratio is presently 3.23%.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research note on Friday, February 14th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the company a "buy" rating in a research note on Monday, April 14th. Finally, Citigroup upped their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $96.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.